Improvements in the diagnostic testing of Alzheimer’s Disease (AD) have led to an earlier diagnosis, for example in the stage of mild cognitive impairment (MCI). Due to this early diagnosis, the label of MCI entails a prognosis, rather than a diagnosis. As a result, the clinician faces a number of challenges during the diagnostic work-up; which and how many tests to use, how to engage patients in decision making and how to communicate test results?
ADappt is an online tool, developed for memory clinic clinicians, to support the diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease. The tool consists of three modules that 1) facilitates the interpretation and 2) communication of AD biomarkers and 3) supports clinicians to engage patients in decision making regarding the diagnostic work-up of AD. The tool is developed in co-creation with end-users (clinicians, patients and caregivers) and usability testing showed that the tool was considered valuable by clinicians, patients and caregivers.